Active · per the CBE, 16 September 2026

TURNHOUTS OOGHEELKUNDIG CENTRUM

BE0434703916

Rechtspersoon Private limited company 1 establishment

Oude Vaartstraat 36 box 1, 2300 Turnhout

Behind the company: Joyce Jansen BV, VC Ophthalmology BV, Dr. Caroline Janssen BV, Sophie Bataillie BV.

Active for

38 year, 2 months

Financials

Financial year 2025

TURNHOUTS OOGHEELKUNDIG CENTRUM from Turnhout, company number BE0434703916, closed financial year 2025 with a result of € 11,338 after tax. For that financial year TURNHOUTS OOGHEELKUNDIG CENTRUM recorded a gross margin of € 34,342 and equity of € 359,013. Compared with financial year 2024, the result moved from € 12,610 to € 11,338. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 6, 2026.

What it is worth Growing

€ 359,013

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 11,338

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,900

▲ 105% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 127,145.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 400

▼ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,850

▲ 87% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 53,338 € 58,605 € 36,331 € 34,342 ▼ 5%
Profit after taxes € 701 € 6,269 € 12,610 € 11,338 ▼ 10%
Equity € 346,550 € 335,066 € 347,675 € 359,013 ▲ 3%
Total debts € 297,359 € 313,946 € 5,213 € 9,250 ▲ 77%
Cash € 193,012 € 229,450 € 28,688 € 58,900 ▲ 105%
Land & buildings € 353,875 € 339,038 € 324,201 € 309,363 ▼ 5%
Retained profit € 114,682 € 103,198 € 115,807 € 127,145 ▲ 10%
Dividend € 0 € 17,753 € 0 € 0
Bank debt € 14,331 € 981 € 0 € 0
Balance sheet total € 643,909 € 649,012 € 352,888 € 368,263 ▲ 4%

Key figures of TURNHOUTS OOGHEELKUNDIG CENTRUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to TURNHOUTS OOGHEELKUNDIG CENTRUM?

What happened at TURNHOUTS OOGHEELKUNDIG CENTRUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 11,338 (▼ 10% vs 2024). Source: NBB ↗
  • Joyce Jansen BV became a director. NBB
  • VC Ophthalmology BV became a director. NBB
  • Dr. Caroline Janssen BV became a director. NBB
  • Sophie Bataillie BV became a director. NBB
  • New establishment in Turnhout. KBO
  • Start of the company according to the CBE. KBO

In short

From € 701 profit in 2022 to € 11,338 profit in 2025.

Paid € 10,593 in corporate taxes since 2022.

Best year ever: 2024, with € 12,610 profit.

Paid out € 17,753 in dividends to the owners in total.

Management

The stake of Sophie Bataillie, Joyce Jansen, VC Ophthalmology comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

TURNHOUTS OOGHEELKUNDIG CENTRUM

Behind TURNHOUTS OOGHEELKUNDIG CENTRUM are Joyce Jansen BV, VC Ophthalmology BV, Dr. Caroline Janssen BV and Sophie Bataillie BV. The shares are held by Sophie Bataillie (25%), Joyce Jansen (25%) and VC Ophthalmology (25%).

See the full network in the app

Directors

According to the 2025 annual accounts

Joyce Jansen BV

Director · represented by Joyce Jansen

since 2024

VC Ophthalmology BV

Director · represented by Sophie Van Camp

since 2024

Dr. Caroline Janssen BV

Director · represented by Caroline Janssen

since 2024

Sophie Bataillie BV

Director · represented by Sophie Bataillie

since 2024

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Oude Vaartstraat 36 box 1

2300 Turnhout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0434.703.916
VAT number
BE 0434.703.916
Registered office
Oude Vaartstraat 36 bus 1, 2300 Turnhout
Names & denominations
TURNHOUTS OOGHEELKUNDIG CENTRUM · T.O.C.
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 July 1988
Peppol
Active · Active since 25 Apr 2025

Frequently asked questions

What is the address of TURNHOUTS OOGHEELKUNDIG CENTRUM?
The registered office of TURNHOUTS OOGHEELKUNDIG CENTRUM is located at Oude Vaartstraat 36 box 1, 2300 Turnhout.
Is TURNHOUTS OOGHEELKUNDIG CENTRUM still active?
Yes. According to the CBE (16 September 2026) TURNHOUTS OOGHEELKUNDIG CENTRUM is active, legal situation “Normale toestand”, started on 1 July 1988.
Is TURNHOUTS OOGHEELKUNDIG CENTRUM registered on Peppol?
Yes, TURNHOUTS OOGHEELKUNDIG CENTRUM is registered on the Peppol network with ID 0208:0434703916.
What is the enterprise number of TURNHOUTS OOGHEELKUNDIG CENTRUM?
The enterprise number of TURNHOUTS OOGHEELKUNDIG CENTRUM is BE0434703916.
When was TURNHOUTS OOGHEELKUNDIG CENTRUM founded?
TURNHOUTS OOGHEELKUNDIG CENTRUM was founded on 1 July 1988.
Who owns TURNHOUTS OOGHEELKUNDIG CENTRUM?
Behind TURNHOUTS OOGHEELKUNDIG CENTRUM are Joyce Jansen BV, VC Ophthalmology BV, Dr. Caroline Janssen BV and Sophie Bataillie BV. The shares are held by Sophie Bataillie (25%), Joyce Jansen (25%) and VC Ophthalmology (25%).